OAC in Patients With AF and COVID-19 Lowers Rates of Death, Thrombotic Events
Researchers assessed the relationship between oral anticoagulation for patients with COVID-19 and AF and incidence of in-hospital thrombotic events and death.
Treatments
Primary Central Nervous System Vasculitis: From Diagnosis to Management
Primary central nervous system vasculitis is an important but rare differential diagnosis in daily neurological practice, warranting the need of a step by step approach.
Amoxicillin Remains Most Effective First-Line Treatment for Acute Otitis Media
Researchers compared the effects of amoxicillin with other broad-spectrum antibiotics on the risk for treatment failure and reinfection in children with uncomplicated acute otitis media.
Noradrenergic Drugs Improve Cognition, Apathy in Alzheimer Disease
Researchers sought to evaluate the efficacy of noradrenergic drugs in the improvement of neuropsychiatric and cognitive symptoms in individuals with AD.
Lavender Capsule Combats Fatigue in Patients With Multiple Sclerosis
Researchers sought to determine the efficacy of a lavender capsule on reducing fatigue symptoms in patients with MS.
Hydroxychloroquine Not Associated With Decreased Risk for COVID-19 Hospitalization
Researchers assessed whether early treatment with hydroxychloroquine decreases the risk for hospitalization among patients with mild to moderate COVID-19 infection.
Efficacy of Different Acupuncture Therapies for Primary Insomnia
In a systematic review and meta-analysis, researchers compared and evaluated the effect differences of multiple acupuncture therapies for patients with primary insomnia.
Pediatric Patients With Cardiovascular Disease Receive Multiple Off-Label Drugs
Researchers assessed the off-label use of cardiovascular medications in a home therapy setting for children with congenital or acquired heart disease.
Lithium Did Not Reduce Suicide-Related Events Among Veterans With a History of Suicidality
In this study, patients were stratified by condition and suicide history and randomized to receive 600 mg/d extended-release lithium carbonate or placebo in addition to usual care.
Metformin and Sulfonylurea Use in People With Type 2 Diabetes and COVID-19
COVID-19 can cause additional complications and even death in people with a pre-existing conditions like type 2 diabetes. Researchers studied whether the medications people with type 2 diabetes often take were associated with a risk of dying from the virus.
- Loading...
Loading...
Loading... 
Loading...